Lincoln Pharmaceuticals Ltd
company logo

Lincoln Pharmaceuticals Ltd

Small Cap


- (0%)

Lincoln Pharmaceuticals Ltd Performance










Lincoln Pharmaceuticals Ltd Fundamentals








i buttonClick here to know more about Fundamentals

Lincoln Pharmaceuticals Ltd Financials

Lincoln Pharmaceuticals Ltd Financialsright-arrow

Lincoln Pharmaceuticals Ltd Shareholding Pattern

Lincoln Pharmaceuticals Ltd Delivery and Volume

About Lincoln Pharmaceuticals Ltd

Lincoln Pharmaceuticals Limited, promoted by Mahendra G Patel, Rajnikant G Patel and Hasmukhbhai I Patel, as a Partnership Firm in Jan 1979 to manufacture pharmaceutical formulations was converted into a Public Limited Company in Jan. '95. All the assets and business of the erstwhile partnership wer

Mahendra G Patel



Kishorbhai M ShahChairman (Non-Executive)
Mahendra G PatelManaging Director
Hasmukhbhai I PatelWhole-time Director
Pirabhai R SutharIndependent Director
Munjal Mahendrabhai PatelWhole-time Director
Aashish R PatelWhole-time Director
Meha PatelIndependent Director
Saurin J ParikhIndependent Director
Rajnikant G PatelDirector
Anand Arvindbhai PatelWhole-time Director
Trusha ShahCompany Sec. & Compli. Officer
News and Events...

Similar Stocks

What's Trending

Lincoln Pharmaceuticals Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Lincoln Pharmaceuticals Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Lincoln Pharmaceuticals Ltd's share price is ₹648.8 as of 2024-07-13.
Lincoln Pharmaceuticals Ltd's P/E ratio is 13.9 times as of 2024-07-13.
Lincoln Pharmaceuticals Ltd's most recent financial reports indicate a price-to-book ratio of 2.19, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Lincoln Pharmaceuticals Ltd's market capitalization is ₹1297.23 Cr as on 2024-07-13.
The current financial records of Lincoln Pharmaceuticals Ltd show a 15.59% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Lincoln Pharmaceuticals Ltd's most recent financial filings, the company has a total asset value of ₹276.38, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Lincoln Pharmaceuticals Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Lincoln Pharmaceuticals Ltd's 52-week high and low as of 2024-07-13 are ₹661.8 and ₹645.05, respectively.